Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) shares dropped more than 46%...
There's one tech-related area that's particularly attractive to investors right now. And it's an industry that Wall Street had all but written...
Biotech stocks have seriously outperformed the markets in 2015, and our favorite biotech ETF has been one of the biggest winners. In...
For weeks now biotech stocks have headlined our list of top stocks to invest in for 2015.
And a particular biotech ETF is showing...
This ETF list is considered a stock market delicacy - it's comprised of the most promising, profitable exchange-traded funds.
From...
If you're looking for the best biotech stocks on the market, you've come to the right place.
Our biotech specialists aren't...
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics,...
Since April 11, Gilead Sciences (Nasdaq: GILD) has scored peak gains of a 74.2% - or more than 175% annualized...
